Canadian Securities Administrators Proposes Amendments and Changes to Corporate Governance Disclosure Practices and Guidelines
The Canadian Securities Administrators (CSA) has published for comment proposed amendments and changes to: (i) Form 58-101F1 Corporate Governance Disclosure (Form 58-101F1) of National Instrument 58-101 Disclosure of Corporate Governance Practices (NI 58-101), and (ii) National Policy 58-201 Corporate Governance Guidelines (NP 58-201) for non-venture issuers (the “Proposed Amendments and Changes”). If implemented, the Proposed Amendments and Changes would increase further transparency on board nominations, board renewal, and diversity, while retaining the current disclosure requirements with respect to women.
The comment period for the Proposed Amendments and Changes is open until July 12, 2023.
Background
Form 58-101F1 currently requires non-venture issuers to provide annual disclosure on director term limits and procedures of board renewal, policies and consideration given for the representation of women on the board and in executive officer positions, along with targets and the current number of women on the board and in executive officer positions.
Additionally, certain legislative measures have been introduced to emphasize the importance of considering diversity on boards and in executive officer positions beyond women. For example, from January 1, 2020, the Canada Business Corporations Act (CBCA) required distributing corporations to expand their diversity disclosure to include Indigenous peoples, persons with disabilities and members of visible minorities. For further details, see our August 8, 2019 Update, CBCA Diversity Disclosure Requirements Effective for 2020 Proxy Season.
Following the CBCA amendments, CSA Staff consulted with stakeholders to better understand their perspectives with respect to diversity. While some stakeholders expressed support for a consistent and prescriptive framework for diversity disclosure, others emphasized the need for a flexible approach and expressed concern with the disclosure of personal characteristics. As a result, the CSA published the Proposed Amendments and Changes and is seeking further commentary from market participants.
Proposed Amendments and Changes
Form 58-101F1
The CSA provided two versions of Form 58-101F1 for comment, being Form A and Form B. Each Form substantially maintains the existing disclosure requirements with respect to women, and is designed to provide investors with information that enables them to better understand how diversity, more broadly, is addressed by non-venture issuers.
Form A requires that the issuer describe how the board identifies and evaluates new candidates for nominations and addresses renewals and reports data on the representation of specific groups on the board and in executive officer positions, if collected. The general intent is to provide issuers with flexibility to design their own practices and policies, without a mandatory requirement to collect any specific data. This less prescriptive approach differs from the approach outlined in the CBCA, which requires disclosure for specifically identified groups of people. Securities regulators in British Columbia, Alberta, Saskatchewan, and the Northwest Territories support Form A.
Form B provides for mandatory reporting on board and executive officer representation of five designated groups: (i) women, (ii) Indigenous peoples, (iii) racialized persons, (iv) persons with disabilities, and (v) LGBTQ2SI+ persons. This approach is more consistent with the CBCA requirements, except that Form B also includes LGBTQ2SI+ persons. Under Form B, disclosure data will have to be reported in a standardized tabular format to promote consistency and comparability. The Ontario Securities Commission supports Form B.
Notably, the securities regulators in Quebec, New Brunswick, Manitoba, Nova Scotia, Newfoundland and Labrador, Nunavut, the Yukon, and Prince Edward Island have yet to express a preference as between Form A and Form B.
NP 58-201
The proposed changes to NP 58-201 would complement the diversity disclosure requirements contained in Form 58-101F1 by providing enhanced guidelines (not prescriptive rules) for both non-venture issuers and venture issuers regarding: (i) the responsibilities of the nominating committee, (ii) the adoption of a written policy respecting the director nomination process, (iii) the use of a composition matrix (commonly referred to as a skills matrix), (iv) effective succession planning and the mechanisms of board renewal (which may include the use of term limits, effectiveness assessments and a composition matrix), (v) the adoption of a written diversity policy, and (vi) setting objectives for achieving diversity in the composition of its board and executive officer positions (which may include diversity targets, establishing a diversity council, implementing training and leadership programs, and expanding strategic outreach directed at developing a diverse pipeline of candidates for director and executive officer positions).
For further information on the Proposed Amendments and Changes, please contact any member of our Capital Markets Group.
Expertise
Authors
Insights
-
Capital Markets
CSA Finalizes Amendments to Align Non-GAAP Financial Measures Disclosure Framework with IFRS 18
On October 15, 2026, the Canadian Securities Administrators (CSA) published final amendments to National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure (“NI 52-112”) and… -
Banking and Finance
Deleveraging During a Proxy Contest: Lessons from the BC Securities Commission’s Decision in Zefiro
The British Columbia Securities Commission (BCSC) recently released its reasons in Re Zefiro Methane Corp., in which it declined to rescind a share issuance that Zefiro Methane Corp. (“Zefiro… -
REITs
The Legal Industry Reviews Edition 11 - REITs Chapter
Bill Gorman, Brenda Gosselin, and Stephen Pincus have co-authored The Canadian REIT Structure in the 11th edition of The Legal Industry Reviews Canada.In this chapter, they examine the evolution of… -
Capital Markets
CSA Proposes Broad Amendments to the Issuer Bid, Take-Over Bid and Beneficial Ownership Reporting Regimes
The Canadian Securities Administrators (CSA) published a notice and request for comment on a broad package of proposed amendments to Canada’s issuer bid, take-over bid and early warning reporting… -
REITs
The Legal Industry Reviews Edition 10 - REITs Chapter
Bill Gorman, Brenda Gosselin, and Stephen Pincus have co-authored The Canadian REIT Structure in the 10th edition of The Legal Industry Reviews Canada.In this chapter, they examine the evolution of… -
Capital Markets
Canadian Securities Administrators Adopt Semi-Annual Reporting Pilot Project
On March 19, 2026, the Canadian Securities Administrators (CSA) announced the adoption of a pilot project (the “SAR Pilot”) that permits eligible venture issuers to voluntarily report on a…
Featured Work
-
Capital Markets
CIBC Capital leads C$400 million Oxford Properties Group Trust debt offering
Goodmans LLP acted for CIBC Capital Markets, as Lead Left Joint Bookrunner, and the agents in connection with a C$400 million senior unsecured notes offering for Oxford Properties Group Trust (“OPGT… -
Banking and Finance
Vital Infrastructure Property Trust completes C$300 million senior unsecured debentures offering
Goodmans LLP acted for Vital Infrastructure Property Trust in connection with its private placement offering of C$300 million aggregate principal amount of 4.865% Series C senior unsecured debentures… -
Capital Markets
Apotex Health Corp. closes $1.25 billion inaugural senior unsecured notes offering
Goodmans LLP acted for Apotex Health Corp. in connection with its private placement offering of $1.25 billion aggregate principal amount of senior unsecured notes… -
Entertainment
WildBrain announces a C$20 million substantial issuer bid
Goodmans LLP is acting for WildBrain Ltd. in connection with its substantial issuer bid to purchase, for cancellation, a number of common shares of the company for an aggregate purchase price not… -
Capital Markets
Apotex Health Corp. completes upsized $850 million bought deal secondary offering
Goodmans LLP acted for Apotex Health Corp. in connection with the closing of the upsized bought deal secondary offering of its common shares by an affiliate of SK Capital Partners, API Investment LP… -
Mergers and Acquisitions
Onex Partners and co-investors acquire AirSprint
Goodmans LLP acted as M&A legal counsel to Onex Partners in connection with the acquisition of AirSprint Inc. by Onex and its co-investors…
News & Events
-
Banking and Finance
Goodmans Recognized in the Best Law Firms - Canada 2027
Goodmans is pleased to be featured in the Best Law Firms - Canada 2027, recognizing us as one of Canada’s most exceptional law firms across 41 industries and practices.We are also honoured to be… -
Aging and Healthcare
Goodmans Honoured with Top-Tier Recognition from Chambers
We are proud to announce Goodmans has received top-tier recognition from Chambers in the Chambers Canada 2027 Guide. Recognition from Chambers is based on independent research and direct client… -
Capital Markets
Goodmans Welcomes Dominique Carli
Goodmans is delighted to announce Dominique Carli has joined the firm as an Associate. Dom’s practice focuses on various areas of corporate law including mergers and acquisitions, private equity…